Fungal infections after hematopoietic stem cell transplantation (Q37739908)

22 August 2017

1 reference

title

Fungal infections after hematopoietic stem cell transplantation (English)

1 reference

stem cell transplantation

22 August 2017

main subject

1 reference

Yuki Asano-Mori

1

1 reference

22 August 2017

publication date

1 May 2010

1 reference

International Journal of Hematology

22 August 2017

published in

1 reference

22 August 2017

volume

91

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

576-587

1 reference

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S12185-010-0574-0

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007/S12185-010-0574-0

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007/S12185-010-0574-0

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

12 December 2020

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

12 December 2020

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

12 December 2020

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

12 December 2020

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia.

1 reference

12 December 2020

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial.

1 reference

12 December 2020

False-positive results of Aspergillus enzyme-linked immunosorbent assay in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

12 December 2020

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes

1 reference

12 December 2020

Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological

1 reference

12 December 2020

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

1 reference

12 December 2020

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

12 December 2020

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

1 reference

12 December 2020

Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis

1 reference

12 December 2020

Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients

1 reference

12 December 2020

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole

1 reference

12 December 2020

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

12 December 2020

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

1 reference

12 December 2020

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan

1 reference

12 December 2020

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

12 December 2020

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

1 reference

12 December 2020

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

12 December 2020

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

1 reference

12 December 2020

Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection

1 reference

12 December 2020

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay

1 reference

12 December 2020

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

1 reference

12 December 2020

Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review

1 reference

12 December 2020

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

1 reference

12 December 2020

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

12 December 2020

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

1 reference

12 December 2020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

12 December 2020

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

1 reference

12 December 2020

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

12 December 2020

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

1 reference

12 December 2020

Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis

1 reference

12 December 2020

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

1 reference

12 December 2020

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

1 reference

12 December 2020

Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

1 reference

12 December 2020

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

1 reference

12 December 2020

Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years

1 reference

12 December 2020

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

1 reference

12 December 2020

Combination antifungal therapy for invasive aspergillosis

1 reference

12 December 2020

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

12 December 2020

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

12 December 2020

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

1 reference

12 December 2020

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

12 December 2020

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

12 December 2020

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

12 December 2020

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

1 reference

12 December 2020

Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole

1 reference

12 December 2020

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

12 December 2020

Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial

1 reference

12 December 2020

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

1 reference

12 December 2020

Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies

1 reference

12 December 2020

False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation

1 reference

12 December 2020

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

1 reference

12 December 2020

10.1007/S12185-010-0574-0

Identifiers

DOI

1 reference

22 August 2017

1 reference